Partner

Mira Launches Ovum Wand to Predict Menopause and Monitor Fertility Status for Women over 35

Mira’s new Ovum Wand provides lab-accurate detection of the follicle-stimulating hormone (FSH) to predict menopause, evaluate fertility and assist in ovulation prediction. The FDA has listed Mira’s new Mira Ovum Wand as an over-the-counter tool to detect the follicle-stimulating hormone (FSH) in urine. Starting October 2022, the product will be available to US customers. The wands help monitor FSH levels to predict…

Meet the 8 Femtech Startups Presenting at HITLAB’s Women’s Health Tech Challenge This Week!

On Friday, December 17th, HITLAB Women’s  Health Tech Initiative will host its fourth annual Women’s Health Tech (WHT) Challenge, where 8 promising femtech founders will pitch their solutions to a panel of judges in an effort to discover the next wave of innovation that can address the unmet needs within women’s health.   The HITLAB WHT Challenge began in 2018, focusing on emerging technology applications and systems that improve medical care and the provision of healthcare among women worldwide.   “The Global market…